Applied Proteomics, Inc. Appoints Steve R. Martin As Chief Financial Officer

SAN DIEGO, Dec. 16, 2014 /PRNewswire/ -- Applied Proteomics Inc., the leading developer of protein-based molecular diagnostics, announced today the appointment of Steve R. Martin as chief financial officer. Mr. Martin has over 30 years of progressive experience in senior financial roles including leadership positions in publicly-traded diagnostic and pharmaceutical companies.

Applied Proteomics Inc., the leading developer of protein-based molecular diagnostics, announced today the appointment of Steve R. Martin as chief financial officer. Mr. Martin has over 30 years of progressive experience in senior financial roles including leadership positions in publicly-traded diagnostic and pharmaceutical companies.
"With more than 30 years of experience from public accounting to financial management, Steve has a depth of hands-on knowledge and exceptional expertise and has managed all aspects of investor relations and financing activities for both public and private companies," said Peter Klemm, Ph.D., President and CEO of Applied Proteomics. "We are excited that Steve has joined the Applied Proteomics team as we continue to pursue our mission of developing novel diagnostics that can inform and improve patient care."

"The team at Applied Proteomics has developed a robust approach to unlock proteomics for a new way to better understand disease," said Mr. Martin. "I look forward to driving strategic financial initiatives to support this high-performance team as they advance the Company's first product, a colorectal cancer detection test, and leverage their proprietary mass spectrometry discovery platform to create new diagnostics."

Mr. Martin was formerly CFO of Apricus Biosciences, a publicly-traded pharmaceuticals company. Prior to Apricus, he was CFO and interim CEO of BakBone Software, where he led the sale of the Company to Quest Software. Before that, Mr. Martin was senior consultant to the CEO and acting chief accounting officer for Leap Communications. Mr. Martin's experience includes leadership roles in two diagnostics and tools companies, including as CFO of Strategene Corporation, sold to Agilent Technologies in 2007 and as controller for Gen-Probe, now a part of Hologic. Mr. Martin began his career at Deloitte and served as senior audit manager and has a B.S. in accounting from San Diego State University.

About Applied Proteomics Inc.

Applied Proteomics Inc. (API) is advancing the application of proteomics to the development of diagnostics, companion diagnostics, and personalized medicine applications to power better medical decisions and care. API has developed a proteomics platform solution to make protein- based biomarker discovery possible as a replicable, industrial application ready to be applied to health diagnostic problems. API's platform combines improved instrumentation, faster computing and extensive genome annotations with regimented standard operating procedures, extensive quality controls, and documented processes spanning hundreds of steps from sample collection to processing through informatics. API is currently advancing several internal diagnostic development programs. API is headquartered in San Diego. For more information, please visit http://www.appliedproteomics.com.

Photo - http://photos.prnewswire.com/prnh/20141215/164534

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/applied-proteomics-appoints-steve-r-martin-as-chief-financial-officer-300010112.html

SOURCE Applied Proteomics Inc.

Suggested Articles

Pillar is bankrolling a new accelerator for budding biotechs. Petri aims to serve biotech startups at the “frontier of biology and engineering.”

One of the last major, late-stage attempt at stopping Alzheimer’s using a BACE inhibitor has ended up on the trash pile with so many others.

The oligosaccharide microbiome modulator was no better than placebo at reducing lactose intolerance symptoms.